193 results on '"Phillips, Gordon L."'
Search Results
152. Preparation for Stem Cell Transplantation
153. Timing of Transplantation
154. Chapter 28 - HIGH-DOSE NITROSOUREA (BCNU) AND AUTOLOGOUS BONE MARROW TRANSPLANTATION: A PHASE I STUDY
155. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
156. Introduction
157. A phase I study of decitabine and rapamycin in relapsed/refractory AML.
158. The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation.
159. Rehabilitation
160. Patterns and Timing of Initial Relapse in Patients Subsequently Undergoing Transplantation for Hodgkin's Lymphoma
161. Future Developments
162. Endocrine Function, Growth, and Development
163. Central Nervous System (CNS)
164. Interstitial Pneumonitis
165. Donor Selection
166. When Should Marrow Transplantation be Considered?
167. Side Effects of Conditioning
168. Chronic Graft-Versus-Host Disease
169. Pulmonary Problems
170. Follow-up after Discharge from the Transplant Center
171. The Management of Infections
172. Urinary Tract
173. Hepatic Dysfunction
174. Acute Graft-versus-Host Disease
175. Marrow Graft Failure
176. Preparation for Marrow Transplantation
177. Collection, Processing and Infusion of Marrow
178. Conditioning Regimens
179. How Should Marrow Transplantation be Approached?
180. Secondary Malignancies
181. Introduction
182. Long-Term Adjustments
183. Ocular Problems
184. Who Pays?
185. Final outcomes of escalated melphalan 280 mg/m 2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
186. Improved outcomes in acute myeloid leukemia patients treated with washed transfusions.
187. A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.
188. A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.
189. Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): how can we improve outcomes in the near future?
190. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
191. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.
192. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.
193. Tandem transplantation in multiple myeloma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.